Sapanisertib

Ovarian Cancer

National Cancer Institute (NCI)Small moleculePhase 1

—

Rating in progress

Sapanisertib in Ovarian Cancer is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.

Methodology v0.2 · Active